Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
Scilipoti P, Rosiello G, Larcher A, Fallara G, Cignoli D, Re C, Musso G, Cei F, Tian Z, Karakiewicz PI, Mottrie A, Trevisani F, Raggi D, Necchi A, Bertini R, Salonia A, Briganti A, Montorsi F, Capitanio U. Scilipoti P, et al. Among authors: re c. World J Urol. 2024 Apr 27;42(1):264. doi: 10.1007/s00345-024-04976-5. World J Urol. 2024. PMID: 38676733
Parenchymal biopsy in the management of patients with renal cancer.
Capitanio U, Larcher A, Fallara G, Trevisani F, Porrini E, Di Marco F, Baiamonte G, Re C, Bettiga A, Dell'Antonio G, Doglioni C, De Cobelli F, Bertini R, Salonia A, Montorsi F. Capitanio U, et al. Among authors: re c. World J Urol. 2021 Aug;39(8):2961-2968. doi: 10.1007/s00345-020-03572-7. Epub 2021 Jan 1. World J Urol. 2021. PMID: 33385247
How to Select the Optimal Candidates for Renal Mass Biopsy.
Martini A, Larcher A, Bravi CA, Capogrosso P, Falagario UG, Fallara G, Pellegrino F, Muttin F, Re C, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U; Young Academic Urologists working groups on robotic surgery and kidney cancer of the European Association of Urology. Martini A, et al. Among authors: re c. Eur Urol Oncol. 2021 Jun;4(3):506-509. doi: 10.1016/j.euo.2020.10.001. Epub 2020 Oct 21. Eur Urol Oncol. 2021. PMID: 34074486
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy.
Rosiello G, Re C, Larcher A, Fallara G, Sorce G, Baiamonte G, Mazzone E, Bravi CA, Martini A, Tian Z, Mottrie A, Bertini R, Salonia A, Briganti A, Montorsi F, Capitanio U, Karakiewicz PI. Rosiello G, et al. Among authors: re c. Eur J Surg Oncol. 2022 Aug;48(8):1840-1847. doi: 10.1016/j.ejso.2022.01.001. Epub 2022 Jan 7. Eur J Surg Oncol. 2022. PMID: 35027234
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma.
Rosiello G, Larcher A, Fallara G, Giancristofaro C, Martini A, Re C, Cei F, Musso G, Tian Z, Karakiewicz PI, Mottrie A, Bertini R, Salonia A, Necchi A, Raggi D, Briganti A, Montorsi F, Capitanio U. Rosiello G, et al. Among authors: re c. Urol Oncol. 2022 Jun;40(6):271.e19-271.e27. doi: 10.1016/j.urolonc.2021.12.010. Epub 2022 Feb 6. Urol Oncol. 2022. PMID: 35140049
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma.
Basile G, Rosiello G, Larcher A, Fallara G, Martini A, Re C, Cignoli D, Tian Z, Karakiewicz PI, Mottrie A, Bertini R, Necchi A, Raggi D, Salonia A, Briganti A, Montorsi F, Capitanio U. Basile G, et al. Among authors: re c. Urol Oncol. 2022 Aug;40(8):384.e15-384.e21. doi: 10.1016/j.urolonc.2022.05.012. Epub 2022 May 31. Urol Oncol. 2022. PMID: 35662498
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?
Fallara G, Larcher A, Rosiello G, Raggi D, Marandino L, Martini A, Basile G, Colandrea G, Cignoli D, Belladelli F, Re C, Musso G, Cei F, Bertini R, Briganti A, Salonia A, Montorsi F, Necchi A, Capitanio U. Fallara G, et al. Among authors: re c. World J Urol. 2022 Nov;40(11):2667-2673. doi: 10.1007/s00345-022-04153-6. Epub 2022 Sep 20. World J Urol. 2022. PMID: 36125505
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy-A large, retrospective, single-center study.
Rosiello G, Larcher A, Fallara G, Cignoli D, Re C, Martini A, Tian Z, Karakiewicz PI, Mottrie A, Boarin M, Villa G, Trevisani F, Marandino L, Raggi D, Necchi A, Bertini R, Salonia A, Briganti A, Montorsi F, Capitanio U. Rosiello G, et al. Among authors: re c. Urol Oncol. 2023 Mar;41(3):149.e17-149.e25. doi: 10.1016/j.urolonc.2022.10.008. Epub 2022 Nov 9. Urol Oncol. 2023. PMID: 36369233
182 results